> Back to seminars list

Seminar

Friday, January 18th, 2019
11h30
Centre de Recherche - Paris - Amphithéâtre Hélène Martel-Massignac

Precise and imprecise therapeutic targeting of sarcomas across the age spectrum

The biological and clinical diversity of sarcomas represents both a scientific opportunity and a medical challenge.  Although cytotoxic chemotherapy can be curative for an important subset of patients, advances in technology have allowed us to identify mechanisms of oncogenic drivers and therapeutically target different subtypes of mesenchymal malignancies to improve clinical outcomes.  Extrapolating from sarcoma, many of the lessons about therapeutic targeting and mechanisms of sensitivity and resistance have implications for other common forms of cancer, as well as inflammatory and fibrotic diseases.  An overview of these promising and inter-related fields of research and clinical care will be presented with an eye towards the future convergence of research and patient care.

Event poster

Speaker(s)

Prof. George Demetri
Prof., Harvard Medical School, Boston USA

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston USA

Hosted by

Unit Training

Invited by

Organisateurs du cours : Olivier Delattre, Valérie Laurence, Daniel Orbach, Francois Doz, Sophie Piperno-Neumann et Sandy Azzi-Hatem

Institut Curie

Contact

Organisateurs du cours : Olivier Delattre, Valérie Laurence, Daniel Orbach, Francois Doz, Sophie Piperno-Neumann et Sandy Azzi-Hatem

Institut Curie

Send an e-mail

Unit Training

Send an e-mail

Elodie Mieville

Send an e-mail

Learn more

Dr. Demetri is director of the Center for Sarcoma and Bone Oncology at DFCI, director of the Ludwig Center at Dana-Farber/Harvard Cancer Center, and executive director for Clinical and Translational Research at the Ludwig Institute for Cancer Research.